Abstract. Although it is well known that SR-A I/II plays a significant role in host defense against bacterial and viral infection, the contribution of SR-A I/II to protozoan infection is not well understood. Thus, we examined the possible role of SR-A I/II against murine malarial infection, such as Plasmodium. berghei and P. yoelli, by using SR-A I/II knockout mice with a C57BL/6J genetic background. When SR-A I/II knockout mice were infected with P. berghei NK65 or P. yoelli 17X, their survival rates were not significantly different from wild-type animals. In terms of the kinetics of parasitemia, hematocrit values and the number of white blood cells, there were no significant differences between the genotypes in P. berghei NK65 or P. yoelli 17X infection. Taken together with the findings in our previous report, the SR-A I/II functional contribution to host defense in malarial infection does not seem to be widely extended, and the effect of SR-A I/II seem in collaboration with other, as yet unidentified, gene(s).
Macrophage type I and type II class A scavenger receptors (SR-A I/II) were initially identified and cloned as molecules that mediate the uptake of modified low-density lipoproteins.
1-3 SR-A I/II can bind an extraordinarily wide range of ligands, including bacterial pathogens, 4 and also function as cation-independent macrophage adhesion molecules. 5, 6 SR-A I/II has been shown to bind and facilitate bloodstream clearance of gram-negative bacterial endotoxin such as lipopolysaccharide 7 and lipoteichoic acid, an anionic polymer that expresses on the surface of most gram-positive bacteria. 8 Studies with SR-A I/II knockout mice have revealed that SR-A I/II plays important roles in host defense against bacterial and viral infection, such as Listeria monocytogenes, 6 Staphylococcus aureus, 9 and Herpes simplex virus. 6 Furthermore, SR-A I/II deficiency impair the uptake and elimination of Corynebacterium parvum by macrophages, 10 and BCG (Bacillus Calmette Guerin)-infected mice lacking SR-A I/II are more susceptible to endotoxin shock in response to lipopolysaccharide. 11 Thus, SR-A I/II plays a significant role in host defense against bacterial and viral infection. In protozoan infection, although Nogami and others 12 have reported that SR-A I/II knockout mice with a ICR × 129 mixed genetic background were more susceptible than wild-type mice against Plasmodium berghei infection, little attention has been paid to strain differences for this receptor in terms of susceptibility to infection. In this study, we focused on the possible role of SR-A I/II against murine malarial infection, such as P. berghei and P. yoelli, by using SR-A I/II knockout mice with a C57BL/6J genetic background.
The genetic background of the SR-A I/II knockout mice 6 was replaced by backcrossing into a C57BL/6J strain (CLEA Japan, Tokyo, Japan) for at least eight generations. 13 Genotyping of the SR-A I/II mutation was examined by means of polymerase chain reaction (PCR). TaKaRa, Shiga, Japan) was used in each reaction. Thermocycling was performed in a Bio-Rad icycler. After an initial preheating step for 4 minutes at 94°C to achieve a hot start procedure, 14 the first three cycles consisted of steps of 94°C for 30 seconds, 68°C for 30 seconds, and 72°C for 183 seconds. A touchdown procedure 15, 16 consisting of denaturation at 94°C for 30 seconds and annealing at 67-63°C for 30 seconds with a 1°C decrement per cycle was applied during the subsequent cycles (4-8). The 9-34 cycles each consisted of steps of 94°C for 30 seconds, 63°C for 30 seconds, and 72°C for 183 seconds. After the last cycle, an extension step of 72°C for 5 minutes was included. The amplified samples were subjected to agarose gel electrophoresis, resulting in detection of a 700-bp wild-type allele and a mutant allele with a size of 900 bp. SR-A I/II knockout and wild-type (C57BL/6J) mice were bred and housed in polycarbonate cages and maintained under a specific pathogen-free environment in light-controlled (lights-on, 0500-1900 hours) and air conditioned (temperature, 24 ± 1°C; humidity, 50 ± 10%) rooms. The mice had free access to standard laboratory chow (CA-1; CLEA Japan). Adult mice were used in this experiment.
The P. berghei NK65 and P. yoelii 17X strains were kindly provided by Dr. Waki (Gunma Prefectural College of Health Science) and Dr. Kobayashi (Kyorin University, School of Medicine), respectively. Parasites were frozen, stored, and subsequently maintained by a serial intraperitoneal inoculation of infected red blood cells (IRBCs) diluted with phosphate-buffered saline (PBS) in C57BL/6J mice every 3 days. Parasitized erythrocytes were collected from the blood of the infected mice, washed twice, and diluted with PBS at a concentration of 1 × 10 4 and 5 × 10 6 IRBCs/mL in P. berghei and P. yoelli, respectively. Both SR-A I/II knockout (N ‫ס‬ 5-8) and C57BL/6J mice (N ‫ס‬ 5-8) were inoculated with 0.2 mL of P. berghei or P. yoelli IRBC suspension by intraperitoneal injections. The course of infection was monitored daily or every other day to examine survival rates, parasitemia, he-matocrit value, and the number of white blood cells (WBCs). Parasitemia was determined by calculating the percentage of erythrocytes infected with parasites on thin blood films stained with Giemsa. Hematocrit values and WBC counts were determined by using an auto hematology analyzer (Cell tac ␣, MEK-6358; NIHON KOHDEN, Tokyo, Japan). Infectivity experiments were replicated at least three times to confirm the reproducibility of results. The Animal Care and Use Committee of Obihiro University of Agriculture and Veterinary Medicine reviewed the protocols and confirmed that the animals used in this study were cared for and used under the Guiding Principals for the Care and Use of Research Animals promulgated by Obihiro University of Agriculture and Veterinary Medicine. Survival rates were analyzed statistically by Gehan generalized Wilcoxon method. Other data were analyzed by Student t test.
On day 9 after infection with P. berghei, 84% of SR-A I/II knockout mice and 28% of wild-type mice survived when they were inoculated with 2 × 10 3 IRBCs. However, all of the SR-A I/II knockout and wild-type mice infected with P. berghei died by 11 days after inoculation ( Figure 1A ). There were no significant differences between the genotypes in survival rates after the P. berghei infection (P > 0.05). As shown in Figures 1B to D, similar kinetics in parasitemia, hematocrit value, and WBC counts were observed in both experimental groups. In P. yoelii infection, there were no significant differences between the genotypes in survival rates, parasitemia, hematocrit values, or WBC counts (Figures 2A to D) .
In contrast to this study, Nogami and others 12 reported that SR-A I/II knockout mice were more susceptible than wildtype mice in P. berghei NK65 infection (P ‫ס‬ 0.060). It is well known that there are considerable strain differences in relative susceptibility for malarial infection in mice. [17] [18] [19] [20] It has been reported that histologic changes during the course of P. berghei infection varied among A/J, BALB/c, OF1, CBA, and C57BL mice. High mortality and acute death occurred in A/J, BALB/c, and OF1 mice, with marked cerebral lesions including congestion of meningeal and cerebral veins and capillaries, a blocking of these vessels by heavily parasitized red blood cells, cerebral edema, and hemorrhage, whereas such lesions were only slight in CBA and C57BL mice.
17 When C57BL/6, A/J, BALB/c, and outbred strain CD-1 were challenged with sporozoites of P. berghei ANKA, C57BL/6 mice were the most susceptible, and CD-1 was the most difficult to infect. 18 In P. yoelii infection, NC/Jic mice all died with high parasitemia, whereas 129/SvJ mice all were completely free from malaria parasites in the circulation. 19 Linkage analysis of backcrossing with NC/Jic and 129/SvJ revealed a host resistance locus to rodent malaria on chromosome 9. 19 These data suggest that both infectivity and protection are geneti- cally restricted and that susceptibility to infection is inversely related to protection. Therefore, it is necessary to consider the effects of genetic background in interpretation of data from results of experimental infection. Nogami and others 12 used mice with a ICR × 129 genetic back ground, whereas this study used a C57BL/6J strain of mice. In addition, P. berghei NK65 is known to possess a high degree of pathogenicity and to be fatal when administered to mice, 20, 21 but wild-type mice displayed a chronic infectious course in the report of Nogami and others. 12 In this study, both P. berghei NK65 and P. yoelli 17X exhibited an acute and fatal infection in mice with a C57BL/6J genetic background (Figures 1 and 2) . Furthermore, there were no differences between SR-A I/II knockout and wild-type mice in terms of infectious course after P. berghei NK65 and P. yoelli 17X infection (Figures 1  and 2) .
Taking together previous studies and findings presented here, the contribution of SR-A I/II function to host defense in malarial infection does not seem to be widely extended, and the effect of SR-A I/II might be exhibited in collaboration with other, as yet unknown, gene(s). However, SR-A I/II might be contribute to the host defense for a chronic infectious course in protozoan infection, as shown in the report of Nogami and others. 12 Further studies will be required to examine the contribution of SR-A I/II in protozoan infection by using other mouse malaria such as P. berghei XAT and P. chabaudi. 
